The characteristics and outcomes of critically Ill patients with COVID-19 who received systemic thrombolysis for presumed pulmonary embolism: an observational study

Keyphrases

• Acute Hospital 20%
• Acute Hypotension 20%
• Autopsy 20%
• Chest CT Angiography 20%
• Clinical Suspicion 20%
• COVID-19 100%
• Critically Ill 20%
• Critically Ill Patients 100%
• Dead Space Ventilation 20%
• Deep Vein Thrombosis 60%
• Hemostasis 20%
• High Prevalence 20%
• Hypoxia 20%
• Lung Transplantation 20%
• Microthrombosis 20%
• New York 20%
• Overall Mortality 20%
• Pressors 20%
• Pulmonary Embolism 100%
• Rehabilitation Centers 20%
• Retrospective Cohort Study 20%
• Right Ventricular Strain 80%
• Right Ventricular Thrombus 20%
• Symptomatic Pulmonary Embolism 20%
• Systemic Thrombolysis 100%
• Tissue Plasminogen Activator (t-PA) 80%
• Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO) 20%
• Venous Thromboembolic Disease 20%

Medicine and Dentistry

• Blood Clot Lysis 100%
• Blood Stasis 16%
• Computed Tomography Angiography 16%
• COVID-19 100%
• Deep Vein Thrombosis 50%
• Emergency Care 16%
• Extracorporeal Membrane Oxygenation 16%
• Hypertensive Factor 16%
• Hypotension 16%
• Hypoxia 16%
• Infusion 16%
• Lung Transplantation 16%
• Microthrombus 16%
• Observational Study 100%
• Prevalence 16%
• Pulmonary Embolism 100%
• Retrospective Cohort Study 16%
• Thrombus 16%
• Tissue Plasminogen Activator 66%
• Venous Thromboembolism 16%